Your browser doesn't support javascript.
loading
c-Abl Inhibitors as Disease-Modifying Therapies for Parkinson's Disease: Gaps and Opportunities.
Merchant, Kalpana; Sullivan, James.
Affiliation
  • Merchant K; Neurology Department, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Sullivan J; Vanqua Bio, Chicago, Illinois, USA.
Mov Disord ; 37(1): 3-5, 2022 01.
Article in En | MEDLINE | ID: mdl-35043450
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Neuroprotective Agents Limits: Humans Language: En Journal: Mov Disord Journal subject: NEUROLOGIA Year: 2022 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Neuroprotective Agents Limits: Humans Language: En Journal: Mov Disord Journal subject: NEUROLOGIA Year: 2022 Document type: Article Affiliation country: United States